BIO Professional Development
Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth
Recorded BioBasics 201: Targeted Biologics for the Non-Scientist Master Course
This is the recorded BioBasics 201 course with the same content, interactive exercises, and course materials that are given in the live version. You have three months to view this course.
BioBasics 201: Targeted Biologics for the Non-Scientist is an intensive, nine-hour course focused on vaccines, cell therapies, gene therapies, therapeutic antibodies, and RNA-based drugs. Biopharma’s inspiration for the development of targeted biologics is our own human immune system, so we begin with an in-depth explanation of immunology. The course then focuses on the science, challenges, and medical promise of next-generation targeted biologics. BioBasics 201 is designed for the non-scientist who has taken BioBasics 101 or for those who understand the basics of DNA, RNA, proteins, and cell signaling. BioBasics 201 is taught by industry experts who explain how these complex drugs work in a simple, engaging manner.
BIO members receive a $100 discount. BIO members should use the code BIOTRAINING2022 to register for this course.
Takeaways
- Learn the mechanisms used by the human body to protect itself against disease
- Fluency in vaccine platforms, understanding how each vaccine type protects against disease
- Rationale of therapeutic antibody mechanisms of action, including monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, and checkpoint inhibitors
- Compare and contrast DNA-based and RNA-based therapies and how each cures disease
- Increased knowledge of cell therapy, including all variations of CAR-based therapeutics
Certificate Requirements
- View entire course
- Read all articles
- Answer all knowledge check questions
Learn about the science driving today’s hottest biopharma innovations including CRISPR, CAR-T, gene therapy, and much more...
Gain a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world...
Explore a broad range of issues faced by entrepreneurs from the managerial, scientific, and academic communities...
.png){kind=logo}
